Ahmed M Aribi, M.D.
Hematologist
4.9 (103 RATINGS)
Clinical Expertise
Leukemia
Appointments
Assistant Professor, Division of Leukemia, Department of Hematology & Hematopoietic Cell Transplantation
Ahmed M. Aribi, M.D., joined the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope as an assistant professor and staff physician. Before coming to City of Hope, Aribi was an instructor within MD Anderson’s Department of Leukemia, Division of Cancer Medicine. Aribi completed fellowships at University of California, Los Angeles and MD Anderson, and before that was a resident and intern at Southern University in Springfield, Ill. He received his medical degree from Alfateh University School of Medicine in Libya. He is board certified in internal medicine and holds medical licenses in both California and Texas.
Board Certified in Internal Medicine
ECFMG Certified
State of California Medical License
State of Texas Medical License
1996 - Alfateh University School of Medicine, Libya, M.D.
2008 -2011, Fellow, Department of Hematology, University of California Los Angeles, Los Angeles, CA
2005 -2007, Fellow, Department of Hematology, Leukemia, M.D. Anderson Cancer Center, Houston, TX
2000 - 2002, Postdoctoral Fellow in Neuro- Pharmacology, Department of Pharmacology Baylor College of Medicine, Houston, TX
2003-2005 Southern Illinois University, Springfield, IL
1997, Internal Medicine, Alfateh University affiliated hospitals, Libya
2002 -2003, Department of Internal Medicine, Southern Illinois University, Springfield, IL
2011 - present, Assistant Professor, Hematology & Hematopoietic Cell Transplantation, City of Hope
2007 - 2008, Instructor, Department of Leukemia, Division of Cancer Medicine, University of Texas M.D. Anderson Cancer Center, Houston, Texas
American College of Physicians
American Medical Association
K.S. Sandhu, S. Dadwal, D. Yang, M. Mei, J. Palmer, A. Salhotra, M.A. Malki, A. Aribi, H. Ali, S. Khaled, S.J. Forman, D. Snyder, R. Nakamura, A.S. Stein, G. Marcucci, I. Aldoss, V. Pullarkat, Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous Leukemia, Biology of Blood and Marrow Transplantation. 26 (2020) e322–e327.
I. Aldoss, J. Zhang, M. Mei, M.M.A. Malki, S. Arslan, D. Ngo, A. Aribi, H. Ali, K. Sandhu, A. Salhotra, P. Koller, S. Khaled, A. Artz, D. Snyder, R. Nakamura, S.J. Forman, A.S. Stein, G. Marcucci, V. Pullarkat, Venetoclax and hypomethylating agents in FLT3-mutated acute myeloid leukemia, American Journal of Hematology. 95 (2020) 1193–1199.
A. Salhotra, D. Yang, S. Mokhtari, M.M.A. Malki, H. Ali, K.S. Sandhu, A. Aribi, S. Khaled, M. Mei, E. Budde, D. Snyder, T. Cao, R. Spielberger, G. Marcucci, V. Pullarkat, S.J. Forman, R. Nakamura, A. Stein, I. Aldoss, Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia, Biology of Blood and Marrow Transplantation. 26 (2020) 1084–1090.
I. Aldoss M.D., M.G. Mei, H. Ali, A. Salhotra, E. Budde, V.A. Pullarkat, M.M. Al Malki, G. Marcucci, K.S. Sandhu, R. Nakamura, S.J. Forman, A.S. Stein, S. Khaled, D. Yang, S. mokhtari, R. Spielberger, T. Cao, A.M. Aribi, D. Snyder, Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia, Blood. 26 (2020) 1084–1090. Accepted
A. Salhotra, I. Aldoss, M.G. Mei, A.M. Aribi, H. Ali, E. Budde, V.A. Pullarkat, M.M. Al Malki, G. Marcucci, K.S. Sandhu, R. Nakamura, D. Snyder, S.J. Forman, A.S. Stein, S. Dadwal, K.L. Reckamp, S. Khaled, D. Yang, S. Mokhtari, B. Tegtmeier, T. Cao, R. Spielberger, E.P. Smith, Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage-Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia, Biology of Blood and Marrow Transplantation. (2020).
Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with 5 stars being the highest.
Ratings
4.9
Provider listen carefully to you
4.9
Know important info medical history
4.9
Show respect for what you say
4.9
Spend enough time with you
4.9
Rate provider 0-10
4.9
Recommend this provider office
4.9
Provider explain in way you understand
Reviews
01/23/23
Very understanding caring time well spent with him - Verified patient
12/13/22
[...] and Dr Aribi work very well together. [...] knows my history and is very helpful. - Verified patient
11/15/22
I have recently referred a friend to City of Hope for breast cancer and now is being treated. - Verified patient
10/11/22
Thanks Dr Aribi and [...] - Verified patient
10/04/22
Very helpful and respectful - Verified patient